NCT06585007View on ClinicalTrials.gov

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

January 20, 2029

Study Completion Date

January 20, 2029

Conditions
Castration-resistant Prostate CancerOligoprogressive
Interventions
RADIATION

Radiotherapy

Progression-directed therapy (stereotactic body radiation therapy)

PROCEDURE

metastasectomy

Progression-directed therapy (metastasectomy)

Trial Locations (1)

Unknown

RECRUITING

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER